Komboglyze: new hypoglycaemic combination

Bristol-Myers Squibb and AstraZeneca have launched Komboglyze, a fixed-dose combination of saxagliptin and metformin.

by
The combination tablet is taken twice daily at mealtimes.
The combination tablet is taken twice daily at mealtimes.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package